The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
The Relationship Between Magnitude of Proteinuria Reduction and Risk of End-stage Renal Disease: Results of the African American Study of Kidney Disease and Hypertension
Abstract
BACKGROUND: The magnitude of proteinuria is associated with a graded increase in the risk of progression to end-stage renal disease and cardiovascular events. The objective of this study was to relate baseline and early changes in proteinuria and glomerular filtration rate (GFR) to long-term progression of hypertensive nondiabetic kidney disease. METHODS: Post hoc analysis of a randomized 3 x 2 factorial trial. A total of 1094 African Americans with hypertensive renal disease (GFR, 20-65 mL/min per 1.73 m(2)) were followed up for a median of 3.8 years. Participants were randomized to a mean arterial pressure goal of 102 to 107 mm Hg (usual) or 92 mm Hg or less (lower) and to initial treatment with a beta-blocker (metoprolol), an angiotensin-converting enzyme inhibitor (ramipril), or a dihydropyridine calcium channel blocker (amlodipine) RESULTS: Baseline proteinuria and GFR predicted the rgate of GFR decline. For each 10-mL/min per 1.73 m(2) lower baseline GFR, an associated mean +/- SE 0.38 +/- 0.08-mL/min per 1.73 m(2) per year greater mean GFR decline occurred, and for each 2-fold higher proteinuria level, a mean +/- SE 0.54 +/- 0.05-mL/min per 1.73 m(2) per year faster GFR decline was observed (P < .001 for both). In multivariate analysis, the effect of baseline proteinuria GFR decline persisted. Initial change in proteinuria from baseline to 6 months predicted subsequent progression, with this relationship extending to participants with baseline urinary protein levels less than 300 mg/d. CONCLUSIONS: The change in the level of proteinuria is a predictor of subsequent progression of hypertensive kidney disease at a given GFR. A prospective trial is needed to confirm this observation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Peterson, J. C., Adler, S., Burkart, J. M., Greene, T., Hebert, L. A., Hunsicker, L. G., King, A. J., Klahr, S., Massry, S. G., Seifter, J. L., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-10-199511150-00003 · Cited by 1,342
de Zeeuw, D., Remuzzi, G., Parving, H.-H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E., & Brenner, B. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00653.x · Cited by 975
Agodoa, L. Y. (2001) · JAMA · doi:10.1001/jama.285.21.2719 · Cited by 944
Nephropathy in Patients with Type 2 Diabetes
Remuzzi, G., Schieppati, A., & Ruggenenti, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011773 · Cited by 587
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease
Jafar, T. H., Stark, P. C., Schmid, C. H., Landa, M., Maschio, G., Marcantoni, C., De Jong, P. E., De Zeeuw, D., Shahinfar, S., Ruggenenti, P., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0600031131.x · Cited by 377
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Garg, J. P., & Bakris, G. L. (2002) · Vascular Medicine · doi:10.1191/1358863x02vm412ra · Cited by 278
Lazarus, J. M., Bourgoignie, J. J., Buckalew, V. M., Greene, T., Levey, A. S., Milas, N. C., Paranandi, L., Peterson, J. C., Porush, J. G., Rauch, S., et al. (1997) · Hypertension · doi:10.1161/01.hyp.29.2.641 · Cited by 226
Differential effects of calcium antagonist subclasses on markers of nephropathy progression
Bakris, G. L., Weir, M. R., Secic, M., Campbell, B., & Weis-McNulty, A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00620.x · Cited by 225
Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
Lebovitz, H. E., Wiegmann, T. B., Cnaan, A., Shahinfar, S., Sica, D. A., Broadstone, V. L., Schwartz, S. L., Mengel, M. C., Segal, R., & Versaggi, J. A. (1994) · PubMed · Cited by 219
Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy
Morelli, E., Loon, N., Meyer, T., Peters, W., & Myers, B. D. (1990) · Diabetes · doi:10.2337/diabetes.39.1.76 · Cited by 213
Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy
Lewis, J. B., Berl, T., Bain, R. P., Rohde, R. D., & Lewis, E. J. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70036-3 · Cited by 181
Ruggenenti, P., Perna, A., Gherardi, G., Benini, R., & Remuzzi, G. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70054-0 · Cited by 176
Culleton, B. F., Larson, M. G., Parfrey, P. S., Kannel, W. B., & Levy, D. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00444-7 · Cited by 162
Wright, J. T., Bakris, G., & Greene, T. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00035-7 · Cited by 158
Smith, A. C., Toto, R. D., & Bakris, G. L. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00055.x · Cited by 117
Gassman, J., Greene, T., Wright, J. T., Agodoa, L. Y. C., Bakris, G. L., Beck, G. J., Douglas, J. G., Jamerson, K., Lewis, J. B., Kutner, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070080.21680.cb · Cited by 94
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Bakris, G. L., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.10081 · Cited by 708
Daskalopoulou, S. S., Rabi, D. M., Zarnke, K. B., Dasgupta, K., Nerenberg, K., Cloutier, L., Gelfer, M., Lamarre-Cliche, M., Milot, A., Bolli, P., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.016 · Cited by 684
Metadata
- Authors
- Lea, J.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2005-04-25
- Volume
- 165
- Issue
- 8
- Pages
- 947
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2130827265
- Cited by
- 297
- References
- 21
- FWCI
- 14.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.